Cidara Therapeutics Statistics
Total Valuation
CDTX has a market cap or net worth of $6.97 billion. The enterprise value is $6.56 billion.
| Market Cap | 6.97B |
| Enterprise Value | 6.56B |
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CDTX has 31.50 million shares outstanding. The number of shares has increased by 229.65% in one year.
| Current Share Class | 31.50M |
| Shares Outstanding | 31.50M |
| Shares Change (YoY) | +229.65% |
| Shares Change (QoQ) | +72.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 15.38 |
| P/TBV Ratio | 16.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.62 |
| Quick Ratio | 4.40 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.70% and return on invested capital (ROIC) is -36.75%.
| Return on Equity (ROE) | -68.70% |
| Return on Assets (ROA) | -29.35% |
| Return on Invested Capital (ROIC) | -36.75% |
| Return on Capital Employed (ROCE) | -37.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.86M |
| Employee Count | 38 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +731.63% in the last 52 weeks. The beta is 1.53, so CDTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +731.63% |
| 50-Day Moving Average | 185.09 |
| 200-Day Moving Average | 83.68 |
| Relative Strength Index (RSI) | 84.21 |
| Average Volume (20 Days) | 1,032,048 |
Short Selling Information
The latest short interest is 2.02 million, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 2.02M |
| Short Previous Month | 2.11M |
| Short % of Shares Out | 6.41% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.34 |
Income Statement
| Revenue | n/a |
| Gross Profit | -131.82M |
| Operating Income | -159.91M |
| Pretax Income | -184.80M |
| Net Income | -184.74M |
| EBITDA | -159.78M |
| EBIT | -159.91M |
| Earnings Per Share (EPS) | -$11.11 |
Balance Sheet
The company has $420.02 million in cash and $1.98 million in debt, with a net cash position of $418.04 million or $13.27 per share.
| Cash & Cash Equivalents | 420.02M |
| Total Debt | 1.98M |
| Net Cash | 418.04M |
| Net Cash Per Share | $13.27 |
| Equity (Book Value) | 422.39M |
| Book Value Per Share | 14.40 |
| Working Capital | 346.98M |
Cash Flow
| Operating Cash Flow | -132.94M |
| Capital Expenditures | n/a |
| Free Cash Flow | -132.94M |
| FCF Per Share | -$4.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CDTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -229.65% |
| Shareholder Yield | -229.65% |
| Earnings Yield | -2.65% |
| FCF Yield | -1.91% |
Analyst Forecast
The average price target for CDTX is $128.75, which is -41.84% lower than the current price. The consensus rating is "Buy".
| Price Target | $128.75 |
| Price Target Difference | -41.84% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 216.35% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 24, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
CDTX has an Altman Z-Score of 1.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.34 |
| Piotroski F-Score | 2 |